Zugriffe | |
---|---|
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 155 |
Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | Mai 2024 | Juni 2024 | |
---|---|---|---|---|---|---|---|
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 1 | 1 | 1 | 1 | 4 | 2 | 1 |
Zugriffe | |
---|---|
2021_Yu_etal.pdf | 58 |